Company: BIAF
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010787
Chunk: 81

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 8
Chunk 81
---
 control of approximately 26% of the voting power of our outstanding Common Stock. As a result, investors may
be prevented from affecting matters involving our Company, including:

    ●
    the composition of our board and, through it, any determination with respect to our business direction and policies, including the appointment and removal of officers;

    ●
    any determinations with respect to mergers or other business combinations;

    ●
    our acquisition or disposition of assets; and

    ●
    our corporate financing activities.

Furthermore, this concentration
of voting power could have the effect of delaying, deterring, or preventing a change of control or other business combination that might
otherwise be beneficial to our stockholders. This significant concentration of share ownership may also adversely affect the trading price
for our Common Stock because investors may perceive disadvantages in owning stock in a company that is controlled by a small number of
stockholders.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES
AND USE OF PROCEEDS.

Unregistered Sales of Equity Securities

We did not sell any equity securities during the quarter
ended March 31, 2025, in transactions that were not registered under the Securities Act other than as previously disclosed in our filings
with the SEC.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

Not applicable.

ITEM 4. MINE SAFETY DISCLOSURES.

Not applicable.

ITEM 5. OTHER INFORMATION.

During the three months ended March 31, 2025, no director
or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,”
as each term is defined in Item 408(a) of Regulation S-K.

26

ITEM 6. EXHIBITS.

    Exhibit No.
     
    Title of Document

    3.1
     
    Certificate of Incorporation of the Registrant as filed with the Delaware Secretary of State on March 26, 2014 (Incorporated by reference as Exhibit 3.1 to the Registrant’s Annual Report on Form 10-K (File No. 001-41463) filed with the SEC on April 1, 2024)
  
    3.2
     
    Amended and Restated Bylaws of Registrant (Incorporated by reference as Exhibit 3.6 to the Registrant’s Registration Statement on Form